BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36602514)

  • 21. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
    Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
    Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
    Lim YJ; Song C; Jeon SH; Kim K; Chie EK
    Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
    Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
    Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Propensity Score-Matched Analysis of the Impact of Neoadjuvant Radiation Therapy on the Outcomes of Stage II and III Mucinous Rectal Carcinoma.
    Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Wexner SD
    Dis Colon Rectum; 2024 May; 67(5):655-663. PubMed ID: 38231014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
    Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
    Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
    Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
    Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
    Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.
    Fernandez LM; São Julião GP; Renehan AG; Beets GL; Papoila AL; Vailati BB; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Figueiredo NL; Van De Velde CJH; Habr-Gama A; Perez RO;
    Dis Colon Rectum; 2023 Jan; 66(1):41-49. PubMed ID: 36515514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
    Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
    Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection.
    Fang C; Nie P; Jing P; Zhang Y; Yang L; Yu Y; Wang C; Zhou Z
    Dis Colon Rectum; 2021 Jun; 64(6):689-696. PubMed ID: 33394777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer.
    Hagerty BL; Aversa JG; Dominguez DA; Davis JL; Hernandez JM; McCormick JT; Blakely AM
    Dis Colon Rectum; 2022 Oct; 65(10):1206-1214. PubMed ID: 34897212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Pathologic Complete Response for Rectal Cancer Based on Pretreatment Factors Using Machine Learning.
    Chen KA; Goffredo P; Butler LR; Joisa CU; Guillem JG; Gomez SM; Kapadia MR
    Dis Colon Rectum; 2024 Mar; 67(3):387-397. PubMed ID: 37994445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omission of or Poor Response to Preoperative Chemoradiotherapy Impacts Radial Margin Positivity Rates in Locally Advanced Rectal Cancer.
    Ore AS; Dombek GE; Cordova-Cassia CA; Quinn JF; Cataldo TE; Schlechter BL; Abrams MJ; Messaris E
    Dis Colon Rectum; 2021 Jun; 64(6):669-676. PubMed ID: 33955406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management and Outcomes of Pathologic Upstaging of Clinical Stage I Rectal Cancers: An Exploratory Analysis.
    Lussiez A; Rivard SJ; Hollingsworth K; Abdel-Misih SRZ; Bauer PS; Hrebinko KA; Balch GC; Maguire LH
    Dis Colon Rectum; 2023 Apr; 66(4):543-548. PubMed ID: 35849821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Associated With Adjuvant Chemotherapy Noncompliance and Survival in Older Adults With Stage III Colon Cancer.
    Simon HL; Reif de Paula T; Spigel ZA; Keller DS
    Dis Colon Rectum; 2023 Sep; 66(9):1254-1262. PubMed ID: 36574320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.
    Williams H; Thompson HM; Lin ST; Verheij FS; Omer DM; Qin LX; Garcia-Aguilar J;
    Dis Colon Rectum; 2024 Mar; 67(3):369-376. PubMed ID: 38039292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage Surgery With Organ Preservation for Patients With Local Regrowth After Watch and Wait: Is It Still Possible?
    Fernandez LM; Figueiredo NL; Habr-Gama A; São Julião GP; Vieira P; Vailati BB; Nasir I; Parés O; Santiago I; Castillo-Martin M; Carvalho C; Parvaiz A; Perez RO
    Dis Colon Rectum; 2020 Aug; 63(8):1053-1062. PubMed ID: 32692070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
    Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
    Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.